Advertisement

  1. National

Breast cancer drug plans

Women in England and Wales with a family history of breast cancer could be offered preventative medication on the NHS, the drug watchdog National Institute of Health and Clinical Excellence has suggested in a consultation.

View all 7 updates ›

Women with a high risk of breast cancer could be offered 'preventative' drugs

A previous clinical trial found that tamoxifen, taken for five years, reduced the risk of developing invasive breast cancer by about 50% in post-menopausal women who were at increased risk of getting the disease.

Another trial found that five years of raloxifene reduces breast cancer risk in such women by about 38%.

Under the new plans, high risk post-menopausal women could be offered the drugs for a period of five years unless they have a history of thromboembolic disease or endometrial cancer.

More top news